Journal of Comparative Effectiveness Research

Top Research Topics at Journal of Comparative Effectiveness Research?

Journal of Comparative Effectiveness Research was organized to reinforce research efforts on Internal medicine, Comparative effectiveness research, Health care, Oncology and Randomized controlled trial. Topics in Internal medicine explored in Journal of Comparative Effectiveness Research were investigated in conjunction with research in Surgery and Cardiology. The work on Comparative effectiveness research tackled in Journal of Comparative Effectiveness Research brings together disciplines like Observational study, Research design, Medical education, Outcomes research and Stakeholder engagement.

Health policy is a primary topic of Health care research in it. The journal explores issues in Oncology which can be linked to other research areas like Breast cancer and Chemotherapy. Most of the works presented in it deals with Randomized controlled trial but it intersects with the subject of Physical therapy.

• Internal medicine (30.00%)
• Comparative effectiveness research (23.22%)
• Health care (12.78%)

What are the most cited papers published in the journal?

• Evaluating patient and stakeholder engagement in research: moving from theory to practice (191 citations)
• Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement (167 citations)
• Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities (89 citations)

Research areas of the most cited articles at Journal of Comparative Effectiveness Research:

The journal papers investigate areas of study like Comparative effectiveness research, Health care, Internal medicine, Nursing and Clinical trial. While the most cited papers focused on Comparative effectiveness research, they were also able to explore topics like Psychological intervention, Stakeholder, Family medicine, Risk analysis (engineering) and Stakeholder engagement. The published papers with studies in Clinical trial featured incorporate elements of Cancer, Physical therapy, Generalizability theory, Intensive care medicine and Lung cancer.

What topics the last edition of the journal is best known for?

• Internal medicine
• Surgery
• Disease

The previous edition focused in particular on these issues:

Journal of Comparative Effectiveness Research primarily tackles Internal medicine, Clinical trial, Oncology, In patient and Randomized controlled trial. While Internal medicine is the focus of it, it also provided insights into the studies of Healthcare utilization and Cardiology. Clinical endpoint is a focus of the presented Clinical trial works and it dives deep in Clinical endpoint.

The Oncology study tackled is a key component of adjacent topics in the area of Breast cancer. Journal of Comparative Effectiveness Research facilitates the exploration of In patient in relation to the field of Surgery. The research on Randomized controlled trial discussed in it draws on the closely related field of Physical therapy.

The most cited articles from the last journal are:

• Estimates of the value of life lost from COVID-19 in Ohio. (5 citations)
• Patient-related barriers to some virtual healthcare services among cancer patients in the USA: a population-based study. (3 citations)
• Network meta-analysis of nivolumab plus ipilimumab in the second-line setting for advanced hepatocellular carcinoma. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Journal of Comparative Effectiveness Research (based on the number of publications) are:

• Brian Godman (23 papers) published 5 papers at the last edition,
• Robert W. Dubois (20 papers) absent at the last edition,
• Rob White (17 papers) published 9 papers at the last edition, 4 more than at the previous edition,
• Eugene C. Rich (15 papers) absent at the last edition,
• Steven D. Pearson (12 papers) published 3 papers at the last edition, 2 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Comparative Effectiveness Research (based on the number of publications) are:

• Novartis (29 papers) published 4 papers at the last edition, 2 less than at the previous edition,
• Bristol-Myers Squibb (27 papers) published 2 papers at the last edition, 6 less than at the previous edition,
• University of Pennsylvania (23 papers) published 5 papers at the last edition, 4 more than at the previous edition,
• Mathematica Policy Research (23 papers) absent at the last edition,
• Cornell University (22 papers) published 10 papers at the last edition, 5 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.57% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.69% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.72% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.72% of all publications and 46.88% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Collaboration with Nursing Schools

It's worth highlighting potential connections with leading educational institutions, particularly in fields like nursing, that contribute significantly to health care and medical research. Links with such institutions can promote collaborative research and nurture future researchers. Ohio, as an example, is home to several such highly-rated and accredited nursing schools. Encouraging researchers from these institutions to submit papers to the Journal of Comparative Effectiveness Research can be mutually beneficial. It provides an esteemed platform to the budding researchers and enriches the journal's pool of research in associated areas like internal medicine and health care. Further, the interdisciplinary knowledge from academicians and scholars can provide valuable insights into areas such as Oncology and Randomized Controlled Trials. This connection between academia and research publications signifies a crucial step to establish a strong foundation for future research collaborations. Thus, the Journal of Comparative Effectiveness Research actively looks forward to increasing its engagement with the academic community, fostering an environment for research exploration and creativity.